EPI

Essa Pharma (EPI)

Essa Pharma Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:TSXV:EPI

1 2 3 4 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2021/02/26	08:33	PR Newswire (Canada)	ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders	TSXV:EPI	Essa Pharma Inc
2021/01/13	21:00	PR Newswire (Canada)	ESSA Pharma Announces Clinical Collaboration with Janssen to Evaluate EPI-7386 Combination for Patients with Metastatic Castr...	TSXV:EPI	Essa Pharma Inc
2020/12/16	07:01	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 20...	TSXV:EPI	Essa Pharma Inc
2020/11/25	21:00	PR Newswire (Canada)	ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference	TSXV:EPI	Essa Pharma Inc
2020/10/27	06:01	PR Newswire (Canada)	ESSA Pharma Inc. Announces Delisting from the TSX-V	TSXV:EPI	Essa Pharma Inc
2020/10/25	08:18	PR Newswire (Canada)	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 32nd EORTC-NCI-AACR Symposium	TSXV:EPI	Essa Pharma Inc
2020/10/19	20:00	PR Newswire (Canada)	ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia	TSXV:EPI	Essa Pharma Inc
2020/09/21	20:00	PR Newswire (Canada)	ESSA Pharma to Participate in Oppenheimer Fall Healthcare Life Science & MedTech Summit	TSXV:EPI	Essa Pharma Inc
2020/09/18	06:05	PR Newswire (Canada)	ESSA Pharma Announces the Presentation of Additional Preclinical Data for EPI-7386 at the ESMO Virtual Congress 2020	TSXV:EPI	Essa Pharma Inc
2020/09/14	20:00	PR Newswire (Canada)	ESSA Pharma Announces Fast Track Designation Granted by the FDA to EPI-7386 for the Treatment of Metastatic Castration-Resist...	TSXV:EPI	Essa Pharma Inc
2020/09/10	20:00	PR Newswire (Canada)	ESSA Pharma to Participate in Multiple Upcoming Investor Conferences	TSXV:EPI	Essa Pharma Inc
2020/08/07	09:00	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2020	TSXV:EPI	Essa Pharma Inc
2020/07/31	23:16	PR Newswire (Canada)	ESSA Pharma Completes Public Offering for Aggregate Gross Proceeds of US$48,990,000	TSXV:EPI	Essa Pharma Inc
2020/07/29	22:07	PR Newswire (Canada)	L'OCRCVM permet la reprise de la négociation - EPI	TSXV:EPI	Essa Pharma Inc
2020/07/29	22:05	PR Newswire (Canada)	IIROC Trading Resumption - EPI	TSXV:EPI	Essa Pharma Inc
2020/07/29	10:18	PR Newswire (Canada)	ESSA Pharma Announces Pricing of Public Offering of Common Shares	TSXV:EPI	Essa Pharma Inc
2020/07/29	05:03	PR Newswire (Canada)	Suspension de la négociation par l'OCRCVM - EPI	TSXV:EPI	Essa Pharma Inc
2020/07/29	05:01	PR Newswire (Canada)	ESSA Pharma Announces Proposed Public Offering of Common Shares	TSXV:EPI	Essa Pharma Inc
2020/07/29	05:01	PR Newswire (Canada)	IIROC Trading Halt - EPI	TSXV:EPI	Essa Pharma Inc
2020/07/15	20:00	PR Newswire (Canada)	ESSA Pharma Announces First Patient Dosed in a Phase 1 Clinical Trial of EPI-7386 for Metastatic Castration-Resistant Prostra...	TSXV:EPI	Essa Pharma Inc
2020/06/22	20:30	PR Newswire (Canada)	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at the 2020 American Association for Cancer Research Virtual Annual Me...	TSXV:EPI	Essa Pharma Inc
2020/05/27	20:00	PR Newswire (Canada)	ESSA Pharma to Present at Jefferies Virtual Healthcare Conference	TSXV:EPI	Essa Pharma Inc
2020/05/15	20:30	PR Newswire (Canada)	ESSA Pharma Presents Therapeutic Potential of EPI-7386 at 2020 Virtual American Urological Association (AUA) Annual Meeting	TSXV:EPI	Essa Pharma Inc
2020/05/08	06:05	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2020	TSXV:EPI	Essa Pharma Inc
2020/05/01	06:45	PR Newswire (Canada)	ESSA Pharma Announces FDA Allowance of the Clinical Investigation of EPI-7386 in Prostate Cancer	TSXV:EPI	Essa Pharma Inc
2020/04/14	07:08	PR Newswire (Canada)	ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement	TSXV:EPI	Essa Pharma Inc
2020/03/31	20:00	PR Newswire (Canada)	ESSA Pharma Submits IND for EPI-7386 for Prostate Cancer and Provides Business Update	TSXV:EPI	Essa Pharma Inc
2020/02/28	09:51	PR Newswire (Canada)	ESSA Pharma Inc. Reports Results of Annual General and Special Meeting of Shareholders	TSXV:EPI	Essa Pharma Inc
2020/02/14	07:48	PR Newswire (Canada)	ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2019	TSXV:EPI	Essa Pharma Inc
2020/02/11	08:15	PR Newswire (Canada)	ESSA Pharma Announces Multiple Abstracts Accepted for Presentation at Upcoming Medical and Scientific Symposia	TSXV:EPI	Essa Pharma Inc